Active Ingredient: TAFAMIDIS MEGLUMINE
Proprietary Name: VYNDAQEL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211996
Product Number: 001
Approval Date: May 3, 2019
Applicant Holder Full Name: FOLDRX PHARMACEUTICALS LLC A WHOLLY OWNED SUB OF PFIZER INC
Marketing Status:
Prescription
Patent and Exclusivity Information
